Related Experiment Video
Updated: Aug 6, 2026
08:16
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
31.8K
A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy
Jeffrey A Allen1, Amy E Clarke2, Thomas Harbo3
1Department of Neurology, University of Minnesota, Minneapolis, MN.
Mayo Clinic Proceedings. Innovations, Quality & Outcomes
|January 29, 2024
Summary
Multifocal motor neuropathy (MMN) is a rare, treatable condition causing asymmetric muscle weakness. Early recognition and referral to specialists are crucial for timely diagnosis and management of this immune-mediated neuropathy.
Area of Science:
- Neurology
- Immunology
- Clinical Medicine
Background:
- Multifocal motor neuropathy (MMN) is a rare immune-mediated disorder.
- It presents with asymmetric weakness, primarily affecting distal upper limb muscles.
- MMN can be challenging to distinguish from motor neuron disease and other neuropathies.
Purpose of the Study:
- To provide an overview of Multifocal Motor Neuropathy (MMN).
- To highlight key differential diagnoses for MMN.
- To describe current treatment options for MMN patients.
Main Methods:
- Literature review of MMN.
- Analysis of clinical and electrophysiologic features.
- Comparison with differential diagnoses.
Main Results:
- MMN is characterized by asymmetric weakness and a distinct electrophysiologic finding: motor nerve conduction block at noncompressive sites.
- Differential diagnoses include motor neuron disease, inclusion body myositis, CIDP, and others.
- MMN is a treatable condition.
Conclusions:
- Timely identification of MMN by primary care physicians is essential.
- Referral to neuromuscular specialists facilitates accurate diagnosis.
- Awareness of MMN's features aids in differentiating it from other neurological disorders.
Related Concept Videos
01:20Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...